Victor Chin, MD
Interventional Pain Medicine · Huntsville, ALNPI 1952437345
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,051 of the $3,695 with a category attached, or 82.6%. 13 manufacturers reported payments, led by Abbott at 58.0% of the total. 2025 is the largest year on record at $978, 4.3 times the $228 reported in 2019. That places this record below the midpoint for interventional pain medicine clinicians in AL, where the typical reported total is $4,812.
Across 162 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- SPR Therapeutics, Inc$618
- Boston Scientific$602
- Nevro Corp.$64
- Aesculap Implant Systems, LLC$46
- MML US, Inc.$41
- plus $182 from 7 others
What the payments were for
- Travel & lodging$2587%
- Food & beverage$3,05183%
- Education$38610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 121 | $2,142 |
| SPR Therapeutics, Inc | 3 | $618 |
| Boston Scientific | 23 | $602 |
| Nevro Corp. | 3 | $64 |
| Aesculap Implant Systems, LLC | 1 | $46 |
| MML US, Inc. | 1 | $41 |
| Biodelivery Sciences International, Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Medtronic | 2 | $32 |
| Johnson & Johnson | 1 | $30 |
| Orthogenrx Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,695 in reported general payments places this provider in the 45th percentile of 33 interventional pain medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 741 | $17,021 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 800 | $15,949 |
| MovantikNaloxegol Oxalate | 23 | $11,160 |
| BelbucaBuprenorphine Hcl | 12 | $10,085 |
| Duloxetine Hcl | 535 | $9,001 |
| Lidocaine | 58 | $6,725 |
| Oxycodone Hcl | 212 | $2,498 |
| Pregabalin | 75 | $2,052 |
| Hydromorphone Hcl | 129 | $1,889 |
| Gabapentin | 192 | $1,746 |
| Lubiprostone | 15 | $1,099 |
| Morphine Sulfate ErMorphine Sulfate | 39 | $781 |
| Naloxone Hcl | 12 | $722 |
| Morphine Sulfate | 27 | $635 |
| Tizanidine Hcl | 83 | $625 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Huntsville
- Ted EdwardsHuntsville$2K
- Michael KendrickBirmingham$90K
- Bradley WargoMuscle Shoals$41K
- Jacob VellaMontgomery$28K
- John IronsVestavia$22K
- Richard WebbFoley$18K
- Ryan AlmeidaBirmingham$14K
- Roberto ChangHoover$13K
- Bradley KatzMontgomery$12K
- Thomas MartinHoover$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.